Khiron Life Sciences Corp. (TSX.V: KHRN) (OTCQX: KHRNF) is a vertically integrated medical and CPG cannabis company with core operations in Latin America and operational activity in Europe and North America. Khiron is the leading cannabis company in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low- and high-THC medical cannabis products. The company has filled medical cannabis prescriptions in Peru and has a presence in Mexico, Uruguay, the UK and Spain, as well as Germany, where it is positioned to begin sales of medical cannabis. For more information, visit the company’s website at www.khiron.ca
To view IBN’s virtual coverage of Investor Summit Group’s Q1 Virtual Summit, visit https://ibn.fm/2021InvestorSummitQ1
About InvestorBrandNetwork’s Virtual Coverage
The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at Investor Summit Group’s Q1 Virtual Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]